DE60236849D1 - Diagnose von atherosclerose - Google Patents

Diagnose von atherosclerose

Info

Publication number
DE60236849D1
DE60236849D1 DE60236849T DE60236849T DE60236849D1 DE 60236849 D1 DE60236849 D1 DE 60236849D1 DE 60236849 T DE60236849 T DE 60236849T DE 60236849 T DE60236849 T DE 60236849T DE 60236849 D1 DE60236849 D1 DE 60236849D1
Authority
DE
Germany
Prior art keywords
atherosclerosis
individual
diagnosis
lipoprotein
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236849T
Other languages
English (en)
Inventor
Ivan Mikhailovich Petyaev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60236849D1 publication Critical patent/DE60236849D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/323Arteriosclerosis, Stenosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Eye Examination Apparatus (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DE60236849T 2001-02-15 2002-02-15 Diagnose von atherosclerose Expired - Lifetime DE60236849D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103766.2A GB0103766D0 (en) 2001-02-15 2001-02-15 Diagnostic
PCT/GB2002/000694 WO2002065137A2 (en) 2001-02-15 2002-02-15 Diagnosis of atherosclerosis

Publications (1)

Publication Number Publication Date
DE60236849D1 true DE60236849D1 (de) 2010-08-12

Family

ID=9908827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236849T Expired - Lifetime DE60236849D1 (de) 2001-02-15 2002-02-15 Diagnose von atherosclerose

Country Status (7)

Country Link
US (1) US7713747B2 (de)
EP (1) EP1366369B1 (de)
AT (1) ATE472735T1 (de)
AU (1) AU2002230004A1 (de)
DE (1) DE60236849D1 (de)
GB (2) GB0103766D0 (de)
WO (1) WO2002065137A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8247235B2 (en) 2007-06-08 2012-08-21 Quest Diagnostics Investments Incorporated Lipoprotein analysis by differential charged-particle mobility
US9354200B1 (en) 2008-08-07 2016-05-31 Quest Diagnostics Investments Incorporated Detection apparatus for differential-charged particle mobility analyzer
WO2010059975A2 (en) * 2008-11-21 2010-05-27 Wisconsin Alumni Research Foundation Method for modulating atherosclerosis
EP2488228A4 (de) * 2009-10-18 2018-03-21 Glycorex AB Verfahren und produkte zur blutbehandlung und -reinigung
US9250211B2 (en) 2010-12-30 2016-02-02 Quest Diagnostics Investments Incorporated Magnetic separation of lipoproteins using dextran sulfate
CA2857194A1 (en) * 2011-12-07 2013-06-13 Thomas M. Dillon Igg2 disulfide isoform separation
US11302645B2 (en) 2020-06-30 2022-04-12 Western Digital Technologies, Inc. Printed circuit board compensation structure for high bandwidth and high die-count memory stacks
US11456022B2 (en) 2020-06-30 2022-09-27 Western Digital Technologies, Inc. Distributed grouped terminations for multiple memory integrated circuit systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018886A (en) * 1975-07-01 1977-04-19 General Electric Company Diagnostic method and device employing protein-coated magnetic particles
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
US5985578A (en) * 1991-08-09 1999-11-16 Washington University Autoantibodies and their targets in the diagnosis of peripheral neuropathies
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
CA2172247A1 (en) * 1993-09-29 1995-04-06 Eiji Matsuura Method of assaying oxidized lipoprotein and application thereof
CA2315537A1 (en) * 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses

Also Published As

Publication number Publication date
GB0103766D0 (en) 2001-04-04
US7713747B2 (en) 2010-05-11
GB2389905B (en) 2004-10-06
WO2002065137A3 (en) 2003-05-30
GB2389905A (en) 2003-12-24
AU2002230004A1 (en) 2002-08-28
ATE472735T1 (de) 2010-07-15
US20040137542A1 (en) 2004-07-15
EP1366369A2 (de) 2003-12-03
WO2002065137A2 (en) 2002-08-22
EP1366369B1 (de) 2010-06-30
GB0321080D0 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE386970T1 (de) Zugriffs- und benutzungsmethoden für webseiten
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
DE60228557D1 (de) Candida-nachweis
NO20015096D0 (no) Måling og bruk av molekul¶re interaksjoner
DE50003766D1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
DE69925929D1 (de) Verfahren zur diagnose von isolationsverschlechterungen in unterirdischen kabeln
DE60103451D1 (de) Verfahren und Vorrichtung für das Simulieren von Lasten an Hebezeugen
ATE472735T1 (de) Diagnose von atherosclerose
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
EP1445329A3 (de) Methode und Teststreifen zur Bestimmung von Glukose in Blut
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
DE50010710D1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE50205750D1 (de) Liganden für den nachweis von prionen
ATE306659T1 (de) Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
MX2007007194A (es) Metodo de diagnostico de enfermedades hepaticas.
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
DE60229513D1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
WO2000050904A8 (de) Testkit zur analytik der faktor-viii-spaltenden protease
HUP0402542A2 (hu) Analitikai eljárás bázisos szfingomielináz detektálására és az ennek alkalmazására szolgáló kit
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs
ATE483983T1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
DE60232529D1 (de) Verfahren und vorrichtung zur isolierung und/oder bestimmung eines analyten